Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours

INTRODUCTION: ModraDoc006 is a novel docetaxel tablet formulation that is co-administrated with the cytochrome P450 3A4 and P-glycoprotein inhibitor ritonavir (r): ModraDoc006/r. OBJECTIVES: This study evaluated the effect of food consumed prior to administration of ModraDoc006/r on the pharmacokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermunt, Marit A. C., de Weger, Vincent A., Janssen, Julie M., Lopez-Yurda, Marta I., Keessen, Marianne, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin D. R., Beijnen, Jos H., Marchetti, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937587/
https://www.ncbi.nlm.nih.gov/pubmed/33464545
http://dx.doi.org/10.1007/s40268-020-00336-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937587/
https://www.ncbi.nlm.nih.gov/pubmed/33464545
http://dx.doi.org/10.1007/s40268-020-00336-x

Ejemplares similares